Spravato (Esketamine) Treatment for Depression
Spravato® (esketamine) is an FDA-approved prescription nasal spray used in conjunction with an oral antidepressant to treat adults with treatment-resistant depression (TRD) or major depressive disorder (MDD) with suicidal thoughts or behaviors. Unlike traditional antidepressants, which work on serotonin and other neurotransmitters and may take weeks to become effective, Spravato targets a different system in the brain—the NMDA receptor—to promote rapid improvements in mood, often within hours to days.
